undamentalytics Newsletter

Hlavinka Sarah E.: insider trades

Officer, Director at 3 companies we cover. 1 open-market purchase and 17 sales not made under a pre-set plan, reported from June 7, 2013 to August 11, 2022.

Would copying Hlavinka Sarah E.’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 1 purchase has 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on August 12, 2022 into $28,094 by November 2, 2026, +27.9% a year. The copy held shares only 24% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $12,346, +5.1% a year (the S&P 500 held throughout made $18,732, +16.1% a year). Beta against the index was 0.53. Twelve months after each report, the average purchase was +149.2% against the S&P 500 (median +149.2%), and 100% beat it. Measured from the trade date, the insider’s own timing, the average was +141.4%. After their sales, the shares moved −12.9% against the index over 12 months on average (a negative figure means selling was the right call); 77% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$10.0k$20.0k$30.0k 20222023202420252026 $28.1k$18.7k$12.3k
Copying Hlavinka Sarah E.S&P 500, same days investedS&P 500, held throughout $10,000 copying Hlavinka Sarah E.’s open-market purchases from August 12, 2022, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
+27.9%
S&P 500, same days invested
+5.1% (held throughout +16.1%)
Time in shares
24%
Sharpe ratio (S&P 500)
0.68 (0.73)
Biggest drop (S&P 500)
−32% (−19%)
Market sensitivity (beta)
0.53
Purchases copied
1

Trade by trade

Hlavinka Sarah E.: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 1 +19.3% +19.3% 100% 1 — — Not enough years
Purchases, 6 months after the report 1 +32.3% +32.3% 100% 1 — — Not enough years
Purchases, 12 months after the report 1 +149.2% +149.2% 100% 1 — — Not enough years
Purchases, 12 months after the trade 1 +141.4% +141.4% 100% 1 — — Not enough years
Sales, 3 months after the report 17 −1.3% −0.3% 53% 9 −0.42 0.69 No reliable evidence
Sales, 12 months after the report 17 −12.9% −9.1% 77% 9 −1.73 0.12 No reliable evidence
Sales, 12 months after the trade 17 −14.4% −9.2% 71% 9 −2.29 0.051 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
ABM Industries Inc ABM EVP/GEN. COUNSEL/CORP. SECTY.010June 7, 2013January 4, 2017
Itron, Inc. ITRI SVP, Gen. Counsel & Corp. Sec.07September 16, 2019February 28, 2022
Quanterix Corp QTRX —10August 11, 2022August 11, 2022

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
August 11, 2022August 11, 2022 QTRX Purchase $100,442 +19.3%+149.2%+141.4%
February 28, 2022February 25, 2022 ITRI Sale $49,006 +7.1%+19.7%+10.0%
February 24, 2022February 22, 2022 ITRI Sale $93,398 +0.4%+10.0%+8.9%
September 15, 2021September 13, 2021 ITRI Sale $31,300 −20.7%−25.2%−26.5%
February 24, 2021February 22, 2021 ITRI Sale $246,826 −28.7%−67.3%−59.1%
September 15, 2020September 14, 2020 ITRI Sale $23,032 +39.3%−2.2%+4.9%
February 26, 2020February 24, 2020 ITRI Sale $76,142 −15.9%+25.7%+1.4%
September 16, 2019September 13, 2019 ITRI Sale $234,289 +4.0%−37.0%−37.6%
January 4, 2017January 3, 2017 ABM Sale $168,799 −0.3%−25.3%−28.4%
January 3, 2017December 30, 2016 ABM Sale $254,209 −2.5%−28.1%−28.6%
December 30, 2016December 29, 2016 ABM Sale $395,196 −0.3%−28.4%−27.2%
December 21, 2016December 21, 2016 ABM Sale $303,880 +3.5%−24.8%−24.0%
October 6, 2016October 3, 2016 ABM Sale $331,455 −3.9%−8.4%−10.8%
June 14, 2016June 13, 2016 ABM Sale $385,112 +4.3%−5.0%−5.0%
April 13, 2015April 10, 2015 ABM Sale $273,525 +1.4%+2.0%+2.6%
March 10, 2014March 7, 2014 ABM Sale $215,946 −8.9%−5.0%−7.1%
September 10, 2013September 6, 2013 ABM Sale $301,766 −2.1%−9.1%−8.6%
June 7, 2013June 6, 2013 ABM Sale $35,920 +1.4%−10.3%−9.2%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Hlavinka Sarah E. traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.